194 related articles for article (PubMed ID: 8641982)
1. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation.
Uchimaru K; Endo K; Fujinuma H; Zukerberg L; Arnold A; Motokura T
Jpn J Cancer Res; 1996 May; 87(5):459-65. PubMed ID: 8641982
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.
Lovec H; Sewing A; Lucibello FC; Müller R; Möröy T
Oncogene; 1994 Jan; 9(1):323-6. PubMed ID: 8302597
[TBL] [Abstract][Full Text] [Related]
3. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.
Spitkovsky D; Steiner P; Gopalkrishnan RV; Eilers M; Jansen-Dürr P
Oncogene; 1995 Jun; 10(12):2421-5. PubMed ID: 7784093
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Jiang W; Kahn SM; Zhou P; Zhang YJ; Cacace AM; Infante AS; Doi S; Santella RM; Weinstein IB
Oncogene; 1993 Dec; 8(12):3447-57. PubMed ID: 8247550
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D and oncogenesis.
Motokura T; Arnold A
Curr Opin Genet Dev; 1993 Feb; 3(1):5-10. PubMed ID: 8453274
[TBL] [Abstract][Full Text] [Related]
6. Ras and Myc can drive oncogenic cell proliferation through individual D-cyclins.
Yu Q; Ciemerych MA; Sicinski P
Oncogene; 2005 Oct; 24(47):7114-9. PubMed ID: 16103884
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 as the putative bcl-1 oncogene.
Harris AW; Bodrug SE; Warner BJ; Bath ML; Lindeman GJ; Adams JM
Curr Top Microbiol Immunol; 1995; 194():347-53. PubMed ID: 7895508
[No Abstract] [Full Text] [Related]
8. Function of a human cyclin gene as an oncogene.
Hinds PW; Dowdy SF; Eaton EN; Arnold A; Weinberg RA
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):709-13. PubMed ID: 8290586
[TBL] [Abstract][Full Text] [Related]
9. Expression of molecular biomarkers in primary breast tumors implanted into a surrogate host: increased levels of cyclins correlate with tumor progression.
Wani G; Noyes I; Milo GE; D'Ambrosio SM
Mol Med; 1997 Apr; 3(4):273-83. PubMed ID: 9131589
[TBL] [Abstract][Full Text] [Related]
10. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells.
Liu JJ; Chao JR; Jiang MC; Ng SY; Yen JJ; Yang-Yen HF
Mol Cell Biol; 1995 Jul; 15(7):3654-63. PubMed ID: 7791772
[TBL] [Abstract][Full Text] [Related]
11. Neoplastic transformation of normal rat embryo fibroblasts by a mutated p53 and an activated ras oncogene induces parathyroid hormone-related peptide gene expression and causes hypercalcemia in nude mice.
Motokura T; Endo K; Kumaki K; Ogata E; Ikeda K
J Biol Chem; 1995 Dec; 270(52):30857-61. PubMed ID: 8537338
[TBL] [Abstract][Full Text] [Related]
12. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.
Boiko AD; Porteous S; Razorenova OV; Krivokrysenko VI; Williams BR; Gudkov AV
Genes Dev; 2006 Jan; 20(2):236-52. PubMed ID: 16418486
[TBL] [Abstract][Full Text] [Related]
13. Signaling by ABL oncogenes through cyclin D1.
Afar DE; McLaughlin J; Sherr CJ; Witte ON; Roussel MF
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9540-4. PubMed ID: 7568169
[TBL] [Abstract][Full Text] [Related]
14. PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma.
Oka K; Ohno T; Yamaguchi M; Mahmud N; Miwa H; Kita K; Shiku H; Shirakawa S
Leuk Lymphoma; 1996 Mar; 21(1-2):37-42. PubMed ID: 8907267
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
Bulavin DV; Tararova ND; Aksenov ND; Pospelov VA; Pospelova TV
Oncogene; 1999 Oct; 18(41):5611-9. PubMed ID: 10523840
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 as a cellular proto-oncogene.
Bates S; Peters G
Semin Cancer Biol; 1995 Apr; 6(2):73-82. PubMed ID: 7647309
[TBL] [Abstract][Full Text] [Related]
17. [Cyclin D1 in oncogenesis].
Hosokawa Y
Seikagaku; 1996 Mar; 68(3):201-5. PubMed ID: 8642209
[No Abstract] [Full Text] [Related]
18. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.
Rowland BD; Bernards R; Peeper DS
Nat Cell Biol; 2005 Nov; 7(11):1074-82. PubMed ID: 16244670
[TBL] [Abstract][Full Text] [Related]
19. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas.
Nikaido T; Li SF; Shiozawa T; Fujii S
Cancer; 1996 Sep; 78(6):1248-53. PubMed ID: 8826947
[TBL] [Abstract][Full Text] [Related]
20. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.
Wang TC; Cardiff RD; Zukerberg L; Lees E; Arnold A; Schmidt EV
Nature; 1994 Jun; 369(6482):669-71. PubMed ID: 8208295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]